Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

stinal side effects were the most common adverse effects and dose modification was effective in many of these patients. HDAC inhibition of 20 percent or more was demonstrated in 78 percent of the eleven patients tested. Subsequent studies, expected to be disclosed later this year, are planned, including consideration of registrational opportunities as a single-agent and/or in combination with other agents in this patient population. Enrollment continues and treatment is ongoing in five patients. This trial is expected to complete enrollment by the end of this year.

"A Phase I/II Study of the Oral Isotype-Selective Histone Deacetylase (HDAC) Inhibitor MGCD0103 in Combination with Azacitidine in Patients with High-Risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML)" (Abstract #7062, Trial 005). The objectives of this study include determining response rates, maximum tolerated dose, safety, tolerability, pharmacokinetics and the degree of inhibition of the target enzyme.

A total of 37 patients were evaluated for activity and 30 of these patients received doses for which clinical activity had previously been documented (MGCD0103 doses of 60mg, 90mg and 110mg). Seventy-eight percent of patients, with their median age being 67 years, had prior chemotherapy. Eleven patients experienced objective clinical responses resulting in a 30 percent response rate for all patients, and a 37 percent response rate in the active dose ranges previously reported. Six of the 11 responders are continuing treatment, with their mean duration on study being about five cycles (approximately five months). Nine responses were seen in AML patients and two in MDS patients. Dose-limiting toxicities were gastrointestinal in nature. The maximum tolerated dose (MTD) was initially determined to be 110mg; however, upon patient treatment expansion at this dose, the MTD was re-evaluated and enrollment continued at starting doses of 90mg three times per week, with Vidaza do
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:12/17/2009)... Dec. 17 SpectraScience, Inc., (OTC Bulletin Board: ... Hitchin has issued the following letter to shareholders: ,, ... pleased to announce that through the recent closing of ... undertaking several initiatives critical to ramping our business performance ... additions to our European sales force. We are increasing ...
(Date:12/17/2009)... LOUIS, Dec. 17 Express Scripts, ... the largest pharmacy benefit management companies in ... study that examined the association of seizure ... A-rated anti-epileptic drug formulations. The study found ... drugs, including brand to generic substitution, was ...
(Date:12/17/2009)... RALEIGH, N.C., Dec. 17 Pharmaceutical Institute ... from GeneEd, Inc., a company specializing in life ... advanced e-courses, help expand Pharmaceutical Institute,s already extensive ... Institute is a leading provider of specialized training ... a subsidiary of Campbell Alliance. Financial terms ...
Breaking Medicine Technology:SpectraScience Releases Shareholder Newsletter 2SpectraScience Releases Shareholder Newsletter 3SpectraScience Releases Shareholder Newsletter 4SpectraScience Releases Shareholder Newsletter 5Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 2Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 3Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 3U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 1U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 2U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 3U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 4Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel 28R 29 51884 1Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 1Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 2Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 3
(Date:12/17/2009)... heels of unveiling the new Stadium to the Sea ... officials today announced a larger-than-ever charity program that will ... from cancer research to gang intervention to cleaning up ... line with the vision of Marathon Owner Frank McCourt, ... a huge philanthropic force in the community. McCourt envisions ...
(Date:12/17/2009)... The following feature is by Devon Herrick, PhD, ... ,, People often assume they have little control ... After all, sickness cannot be scheduled, doctors prescribe treatments ... percent of Americans. However, there are many overlooked ways ... care you need. ,, Cut your ...
(Date:12/17/2009)... DAYTON, Ohio, Dec. 17 Good Samaritan Hospital ... pelvic health issues with the launch of the Good ... ,, The center is designed to help treat two ... incontinence) and slippage of the bladder, uterus or rectum ... some degree of urinary leakage and one out of ...
(Date:12/17/2009)... -- The National Council on Disability (NCD) ... Marriott Houston, 5150 Westheimer, Houston, TX, beginning at 8:30 ... 11:00 a.m. on Thursday, January 21, 2010. This meeting ... it is vital to hear from communities around the ... people with disabilities. This meeting will provide another opportunity ...
(Date:12/17/2009)... show that Chinese research output has increased from just ... 2008. , Faculty of 1000, which selects only ... more than 530 papers from Chinese universities and institutes ... in 2004, this increased by over fourfold in 2008 ... , Jane Hunter, Managing Director of Faculty of 1000, ...
Breaking Medicine News(10 mins):Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 2Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 3Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 4Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:China rapidly catching up in research impact 2
... invites customers to just ,have fun, and use social ... 6 Baxa Corporation, a leading developer of technology ... medications, has joined the social media craze by hosting ... Group. More and more healthcare facilities, medical device ...
... MULTIPLE LIFESTYLE-BASED OFFERINGSLOS ANGELES, April 6 ... FVRL), which through its wholly-owned operating subsidiary, ... Personal Health Records ("PHRs") ( www.mymedicalrecords.com ... storage solutions ( www.myesafedepositbox.com ), ...
... and B-to-C Firm Starts with Several Accounts; Membership ... 6 Feintuch Communications, Inc. ( www.feintuchcommunications.com ... industry veteran and former journalist Henry Feintuch, has ... Avenue in New York City.(Logo: ...
... 2009 New head-to-head clinical trial results demonstrate that ... The five studies conducted by Johnson & Johnson ... during the 87th General Session and Exhibition of the ... , REACH ULTRACLEAN Floss removes up to two ...
... for the Medical Waste Treatment MarketMOUNTAIN VIEW, Calif., April ... medical waste treatment market, Frost & Sullivan recognizes BioMedical ... Frost & Sullivan Award for Product Innovation of the ... innovation, as evidenced by its introduction of the Demolizer(R) ...
... EL SEGUNDO, Calif., April 6 DaVita ... named winner of the 2009 Recruiting Department of the ... ( http://www.ere.net ) presents Recruiting Excellence Awards annually to ... (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO )The ...
Other Medicine News:Health News:Baxa Corporation Gets Social With Facebook and LinkedIn 2Health News:Baxa Corporation Gets Social With Facebook and LinkedIn 3Health News:MMR Information Systems, Inc. Joins With United Marketing Group to Offer Its MyMedicalRecords Personal Health Record and MyEsafeDepositBox Services to Vast Array of Nationally Recognized Partners 2Health News:MMR Information Systems, Inc. Joins With United Marketing Group to Offer Its MyMedicalRecords Personal Health Record and MyEsafeDepositBox Services to Vast Array of Nationally Recognized Partners 3Health News:MMR Information Systems, Inc. Joins With United Marketing Group to Offer Its MyMedicalRecords Personal Health Record and MyEsafeDepositBox Services to Vast Array of Nationally Recognized Partners 4Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 2Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 3Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 4Health News:New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive products 2Health News:BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivan's Product Innovation of the Year Award 2Health News:BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivan's Product Innovation of the Year Award 3Health News:BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivan's Product Innovation of the Year Award 4Health News:DaVita Wins Recruiting Department of the Year Award 2
... a qualitative enzyme immunoassay (EIA) that ... capsid antigen (EBV-VCA), Epstein-Barr early nuclear ... When used in conjunction with Mono-M ... the serodiagnosis of infectious (EBV) mononucleosis ...
... an ELISA method for the qualitative detection of ... (VCA) in human serum. When the VCA IgG ... such as the EBV nuclear antigen (EBNA-1), VCA ... tests, the results can serve as an aid ...
... (Lyme) test is an enzyme ... the qualitative detection of borrelia ... related Borrelia burgdorferi antibodies (IgG, ... in serum as an aid ...
The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi total antibodies (IgG, IgM, and IgA) in serum and is u...
Medicine Products: